"Expanding Product Supply Through Veterinary Clinics"

On June 8, Daewoong Pet announced the launch of 'UDCA Tablet 50mg,' a new low-dose lineup of ursodeoxycholic acid (UDCA) formulations for animals.


Product photo of Daewoong Pet UDCA Tablet 50mg. Daewoong Pet

Product photo of Daewoong Pet UDCA Tablet 50mg. Daewoong Pet

View original image

UDCA Tablet 50mg is the first product in Korea to be approved as a 50mg UDCA tablet for veterinary use. It was developed to improve dosing convenience and enable weight-based prescriptions for small dogs and cats. Previously, animals with lower body weights were often prescribed split or crushed high-dose tablets. However, UDCA Tablet 50mg reduces the burden of such compounding and expands the options for tablet-based prescriptions.



A representative from Daewoong Pet stated, "Interest in managing bile acid metabolism in companion animals is growing. We will strengthen product supply and information sharing through veterinary clinics to provide a more convenient and stable UDCA administration environment for pets."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing